...
首页> 外文期刊>Vaccine >Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18
【24h】

Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18

机译:弓形虫ROP18基因DNA免疫接种对小鼠弓形虫的保护作用

获取原文
获取原文并翻译 | 示例

摘要

Toxoplasma gondii is an obligate intracellular protozoan parasite infecting mammals and birds including humans. Rhoptry protein 18 has been implicated as an important virulence factor. In this study, we constructed a DNA vaccine expressing rhoptry protein 18 (ROP18) of T. gondii. and evaluated the immune response and protective immunity in Kunming mice. The gene sequence encoding ROP18 was inserted into the eukaryotic expression vector pVAX I. Intramuscular immunization of mice with pVAX-ROP18 elicited specific humoral responses and stimulated lymphoproliferation (P < 0.05). The cellular immune response was associated with the production of IFN-gamma, indicating that a Th1 type response was elicited, which was confirmed by the production of large amounts of IgG2a (P < 0.05). By the expression of the CD69, an activation marker of CD4+ and CD8+ T cells, we found that pVAX-ROP18 enhanced the activation of CD4+ and CD8+ T cells in lymphoid in mice. After lethal challenge, the mice immunized with the pVAX-ROP18 showed a significantly increased survival time (27.9 +/- 15.1 days) compared with control mice which died within 7 days of challenge (P < 0.05). Our results show for the first time, that a ROP18 vaccine construct can enhance the T. gondii-specific CTL Th1 responses and increased survival suggested that ROP18 is a promising vaccine candidate against infection with T. gondii
机译:弓形虫是专性的细胞内原生动物寄生虫,可感染哺乳动物和鸟类,包括人。 Rhoptry蛋白18被认为是重要的毒力因子。在这项研究中,我们构建了一种表达弓形虫Rhoptry蛋白18(ROP18)的DNA疫苗。并评估了昆明小鼠的免疫应答和保护性免疫。将编码ROP18的基因序列插入到真核表达载体pVAX I中。用pVAX-ROP18进行的小鼠肌肉内免疫会引起特定的体液反应并刺激淋巴细胞增殖(P <0.05)。细胞免疫应答与IFN-γ的产生有关,表明引发了Th1型应答,这由大量IgG2a的产生所证实(P <0.05)。通过CD69(CD4 +和CD8 + T细胞的激活标记)的表达,我们发现pVAX-ROP18增强了小鼠淋巴中CD4 +和CD8 + T细胞的激活。致死性攻击后,与在攻击后7天内死亡的对照小鼠相比,用pVAX-ROP18免疫的小鼠表现出显着增加的生存时间(27.9 +/- 15.1天)。我们的结果首次显示,ROP18疫苗构建体可以增强弓形虫特异性CTL Th1反应,并提高存活率,表明ROP18是抗弓形虫感染的有前途的候选疫苗

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号